Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radha Rajasingham
David R Boulware

Showing results (21-30 of 435) with videos related to

Pageof 44
Sort By:
Journal of Clinical Microbiology|February 7, 2020
Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal AntigenemiaCaleb Skipper, Kiiza Tadeo, Emily Martyn, et al.
Plos One|January 11, 2019
Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysisRadha Rajasingham, David B Meya, Gregory S Greene, et al.
Emerging Infectious Diseases|July 23, 2024
Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and AfricaPreethiya Sekar, Gila Hale, Jane Gakuru, et al.
The Lancet. Infectious Diseases|December 24, 2022
The urgent need to scale-up fungal diagnostics in AfricaIriagbonse Iyabo Osaigbovo, Radha Rajasingham
The Lancet. Infectious Diseases|September 1, 2022
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysisRadha Rajasingham, Nelesh P Govender, Alexander Jordan, et al.
Open Forum Infectious Diseases|August 18, 2019
Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction ModelSupavit Chesdachai, Radha Rajasingham, Melanie R Nicol, et al.
Clinical Pharmacology and Therapeutics|April 29, 2020
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for EffectivenessMahmoud Al-Kofahi, Pamala Jacobson, David R Boulware, et al.
The Lancet. Infectious Diseases|May 10, 2017
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysisRadha Rajasingham, Rachel M Smith, Benjamin J Park, et al.
Nature Reviews. Disease Primers|November 9, 2023
Cryptococcal meningitisLillian Tugume, Kenneth Ssebambulidde, John Kasibante, et al.
Open Forum Infectious Diseases|April 3, 2023
Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal AntigenemiaAlice Lehman, Elizabeth Nalintya, Abduljewad Wele, et al.
Pageof 44

Showing results (21-30 of 435) with videos related to

Sort By:
Pageof 44
Journal of Clinical Microbiology|February 7, 2020
Evaluation of Serum Cryptococcal Antigen Testing Using Two Novel Semiquantitative Lateral Flow Assays in Persons with Cryptococcal AntigenemiaCaleb Skipper, Kiiza Tadeo, Emily Martyn, et al.
Plos One|January 11, 2019
Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysisRadha Rajasingham, David B Meya, Gregory S Greene, et al.
Emerging Infectious Diseases|July 23, 2024
Systematic Review of Prevalence of Histoplasma Antigenuria in Persons with HIV in Latin America and AfricaPreethiya Sekar, Gila Hale, Jane Gakuru, et al.
The Lancet. Infectious Diseases|December 24, 2022
The urgent need to scale-up fungal diagnostics in AfricaIriagbonse Iyabo Osaigbovo, Radha Rajasingham
The Lancet. Infectious Diseases|September 1, 2022
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysisRadha Rajasingham, Nelesh P Govender, Alexander Jordan, et al.
Open Forum Infectious Diseases|August 18, 2019
Minimum Inhibitory Concentration Distribution of Fluconazole against Cryptococcus Species and the Fluconazole Exposure Prediction ModelSupavit Chesdachai, Radha Rajasingham, Melanie R Nicol, et al.
Clinical Pharmacology and Therapeutics|April 29, 2020
Finding the Dose for Hydroxychloroquine Prophylaxis for COVID-19: The Desperate Search for EffectivenessMahmoud Al-Kofahi, Pamala Jacobson, David R Boulware, et al.
The Lancet. Infectious Diseases|May 10, 2017
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysisRadha Rajasingham, Rachel M Smith, Benjamin J Park, et al.
Nature Reviews. Disease Primers|November 9, 2023
Cryptococcal meningitisLillian Tugume, Kenneth Ssebambulidde, John Kasibante, et al.
Open Forum Infectious Diseases|April 3, 2023
Hyponatremia as a Predictor of Cryptococcal Meningitis and Death Among Asymptomatic Persons With HIV and Cryptococcal AntigenemiaAlice Lehman, Elizabeth Nalintya, Abduljewad Wele, et al.
Pageof 44